PTPRC and Familial prostate cancer: Subsequent to the above experiments, we added Cy5 dye detection capability to the PACS platform for expanded multiplex detection using calcein, a TaqMan assay targeting lymphocytes (PTPRC) and two TaqMan assays specific for prostate cancer cells (VIM and EPCAM, Additional file 4: Figure S4).